Sandbox:Amd: Difference between revisions
Jump to navigation
Jump to search
Line 25: | Line 25: | ||
!Other history/ | !Other history/ | ||
findings | findings | ||
! | !Hypo | ||
natremia | |||
!Cortisol levels | !Cortisol levels | ||
!Gold Standard | !Gold Standard | ||
Line 40: | Line 41: | ||
|✔ | |✔ | ||
|✔ | |✔ | ||
| | |✔ | ||
| | | | ||
| | | | ||
*Autoimmune/idiopathic | *Autoimmune/idiopathic | ||
*Infections- Tuberculosis | *Infections- Tuberculosis, histoplasmosis | ||
|✔ | |✔ | ||
|↓ | |↓ | ||
Line 64: | Line 65: | ||
| | | | ||
* [[Hypopituitarism]]- Tumors, infections. hemorrhage/trauma | * [[Hypopituitarism]]- Tumors, infections. hemorrhage/trauma | ||
* Drugs- Chronic [[steroid]] therapy and its withdrawal, Opiates | * Drugs- Chronic [[steroid]] therapy and its withdrawal, Opiates | ||
* [[Genetics|Genetic]]- Combined pituitary hormone deficiency (CPHD), POMC (Proopiomelanocortin) gene deficiency | * [[Genetics|Genetic]]- Combined pituitary hormone deficiency (CPHD), POMC (Proopiomelanocortin) gene deficiency | ||
| | | - | ||
| | |Normal | ||
| | | | ||
| | | | ||
Line 164: | Line 165: | ||
| | | | ||
|} | |} | ||
<references /> |
Revision as of 19:54, 25 September 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Adrenal Insufficiency
Disease | Clinical history/findings | Causes | Investigations/
Laboratory findings |
Medical management | Surgical management | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hypotension | Skin
pigmentation/ findings |
Hypoglycemia | Anorexia | Abdominal pain | Muscle weakness | Other history/
findings |
Hypo
natremia |
Cortisol levels | Gold Standard | ||||
Differentiating Primary from Secondary adrenal insufficiency | |||||||||||||
Primary adrenal
insufficiency |
✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
|
✔ | ↓ | Cosyntropin/
ACTH stimulation test |
|||
Secondary adrenal
insufficiency |
✔ | - |
|
- | Normal | ||||||||
Differentiating Adrenal Insufficiency from other diseases | |||||||||||||